FDAapproved

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory decision …

UNIVERSITY PARK, Pa. — Increased antibiotic use could lead to antibiotics to more problematic infections as bacteria evolve and resist treatment. Answer to this antibiotic resistance Centers for Disease Control …